Frontier Capital Management’s AngioDynamics ANGO Stock Holding History

Frontier Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-355,370	Closed	-$3.67M	–	265
2023 Q1	$3.67M	Sell	355,370 -32,114	-8%	-$411K	0.04%	236
2022 Q4	$5.34M	Buy	387,484 +74,557	+24%	+$1.04M	0.06%	229
2022 Q3	$6.4M	Sell	312,927 -1,668	-0.5%	-$36.6K	0.08%	222
2022 Q2	$6.09M	Buy	314,595 +26,538	+9%	+$543K	0.07%	234
2022 Q1	$6.21M	Buy	288,057 +62,845	+28%	+$1.43M	0.06%	238
2021 Q4	$6.21M	Sell	225,212 -3,168	-1%	-$87.4K	0.05%	242
2021 Q3	$5.92M	Buy	228,380 +52,970	+30%	+$1.42M	0.05%	252
2021 Q2	$4.76M	Buy	+175,410	New	+$4.28M	0.03%	272

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Frontier Capital Management's ANGO Position: Q2 2023 in Review

Frontier Capital Management sold out of AngioDynamics (ANGO) in Q2 2023, closing a stake of 355,370 shares — an estimated $3.67M sold.

Frontier Capital Management first reported a position in ANGO in Q2 2021 and held it in 8 quarters. The position peaked at $6.4M in Q3 2022. 156 funds tracked by Wall St. Rank hold ANGO as of Q2 2023.

Frontier Capital Management reported no remaining AngioDynamics position as of Q2 2023 after selling out during the quarter.
Frontier Capital Management sold 355,370 AngioDynamics shares in Q2 2023, an estimated $3.67M.
Frontier Capital Management first reported a position in AngioDynamics in Q2 2021 and held it in 8 quarters.
Frontier Capital Management's AngioDynamics position peaked at $6.4M in Q3 2022.
156 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2023.

Based on Frontier Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.